Sandra Kurtin, PhD, ANP-C, AOCN, FAPO

Assistant Professor of Clinical Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona Cancer Center
Tucson, Arizona
Last modified: January 16, 2023
Authored Items
Other than cytopenias, what are signs that my patient is intolerant to ruxolitinib or a JAK inhibitor?
Sandra Kurtin, PhD, ANP-C, AOCN, FAPO
FAQ published on January 16, 2023

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com